HUM vs SEPN · P/E 39, rev $129.66B vs rev $1.1M
Humana Inc (HUM) versus Septerna, Inc. Common Stock (SEPN) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Septerna, Inc. Common Stock (SEPN) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported SEPN revenue for 2024-12-31 was $1.1M. Net income was -$71.8M. Revenue was up 611.9% from 2023-12-31 to 2024-12-31. SEPN currently screens at market cap $1.61B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. SEPN currently screens at market cap $1.61B.
Not investment advice. Open the HUM and SEPN stock pages for the full models.
Not investment advice.